The company's patented IntelliProbe Immunosensor (IPI) platform delivers results in under 60 seconds, significantly faster than existing methods that can take hours or even days. Rapid Diagnostek's sensor has shown promising results in the laboratory, and the company is now working on developing a fully functioning device and initial assays for commercialization. Their products are aimed at various markets, including human and veterinary diagnostics, environmental testing, biohazard and bioterrorism detection, agricultural commodity testing, and food safety testing. Using proprietary technology, Rapid Diagnostek is developing a new generation of in vitro diagnostic tests, leveraging their patented RFPS detection technology and disposable IPI sensor.